Posted by Michael Wonder on 21 Mar 2018
New medicine to help end the transmission of HIV
21 March 2018 - The Australian Government is taking a critical step in helping end the transmission of HIV infection in Australia with the 1 April listing of tenofovir with emtricitabine on the Pharmaceutical Benefits Schedule.
The Turnbull Government is taking a critical step in helping end the transmission of HIV infection in Australia with the 1 April listing of tenofovir with emtricitabine on the Pharmaceutical Benefits Schedule.
Known as Pre-Exposure Prophylaxis (PrEP), the preventative medicine is for people at medium to high risk of HIV infection.
